We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

49 hedge funds and large institutions have $252M invested in Aerie Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 49 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
+49
Holders Change %
–
% of All Funds
1.42%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
49
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
+$57.2M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$21.6M
3
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$5.44M
4
BC
Broadfin Capital
New York
+$5.1M
5
PI
Putnam Investments
Massachusetts
+$4.17M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
EIM
26
Essex Investment Management
Massachusetts
$576K +$418K +32,064 New
Deutsche Bank
27
Deutsche Bank
Germany
$556K +$404K +31,046 New
Bank of New York Mellon
28
Bank of New York Mellon
New York
$425K +$308K +23,650 New
Morgan Stanley
29
Morgan Stanley
New York
$400K +$291K +22,338 New
TCIM
30
TIAA CREF Investment Management
New York
$360K +$261K +20,069 New
BIM
31
BlackRock Investment Management
Delaware
$354K +$257K +19,727 New
BA
32
BlackRock Advisors
Delaware
$297K +$215K +16,526 New
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$251K +$182K +14,000 New
SCA
34
SAC Capital Advisors
Connecticut
$223K +$162K +12,418 New
KeyBank National Association
35
KeyBank National Association
Ohio
$203K +$147K +11,308 New
Charles Schwab
36
Charles Schwab
California
$202K +$146K +11,200 New
CBOA
37
Commonwealth Bank of Australia
Australia
$192K +$139K +10,700 New
RCP
38
Rothschild Capital Partners
New York
$180K +$130K +10,000 New
TA
39
Teachers Advisors
New York
$137K +$99.5K +7,640 New
NFA
40
Nationwide Fund Advisors
Ohio
$104K +$75.5K +5,795 New
AIG
41
American International Group
New York
$92.1K +$66.8K +5,129 New
Citigroup
42
Citigroup
New York
$68K +$49.1K +3,771 New
SO
43
STRS Ohio
Ohio
$56K +$40.4K +3,100 New
TRCT
44
Tower Research Capital (TRC)
New York
$25K +$18.4K +1,409 New
U
45
UBS
Switzerland
$18K +$13K +1,000 New
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$5K +$3.58K +275 New
Bank of America
47
Bank of America
North Carolina
$2K +$1.3K +100 New
Barclays
48
Barclays
United Kingdom
$2K +$1.59K +122 New
BNP Paribas Financial Markets
49
BNP Paribas Financial Markets
France
$1.71K +$1.24K +95 New
1
2

AERI Hedge Fund Activity: Q4 2013 in Review

49 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q4 2013, worth a combined $252M.

Buyers outnumbered sellers: 49 funds opened new AERI positions and 0 closed out — a net gain of 49 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was TPG Group Holdings (SBS) Advisors, opening a new position worth an estimated $57.2M.

  • 49 institutional investors held Aerie Pharmaceuticals (AERI) as of Q4 2013, up from 0 in Q3 2013.
  • Funds reported $252M of Aerie Pharmaceuticals stock for Q4 2013.
  • 49 funds opened new Aerie Pharmaceuticals positions in Q4 2013 and 0 closed out, a net change of +49 holders.
  • The largest Aerie Pharmaceuticals buyer in Q4 2013 was TPG Group Holdings (SBS) Advisors, an estimated $57.2M added.

Based on aggregated 13F filings for Q4 2013.